


Latoxan Revenue
Biotechnology Research • Portes-lès-Valence, Auvergne-Rhône-Alpes, France • 1-10 Employees
Latoxan revenue & valuation
| Annual revenue | $500,000 |
| Revenue per employee | $72,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,600,000 |
| Total funding | No funding |
Key Contact at Latoxan
Harold De Pomyers
President & CEO
Company overview
| Headquarters | Latoxan S.A.S., 845, avenue Pierre Brossolette, Portes-lès-Valence, 26800, FR |
| Phone number | +33475419191 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Dietary Supplements, Research, Life Sciences, Cosmetics, Drug Discovery, Biology, Biochemistry, Pharmaceutics, Biotechnologies, Plant Extracts, Snake Venom, Antivenom, Natural Bioactive Ingredients, Peptides And Toxins, Scorpion Venom, Venom Production, Plant Molecules |
| Founded | 1982 |
| Employees | 1-10 |
| Socials |
Latoxan Email Formats
Latoxan uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@latoxan.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@latoxan.com | 66.7% |
{first initial}.{last name} | j.doe@latoxan.com | 33.3% |
About Latoxan
Laboratory specializing in venom production, venom peptides and plant molecules. LATOXAN produces and sells Natural active Ingredients aimed at Pharmaceutics, Animal Health, Cosmetics, Food and Feed Supplements and Life Science Research. Venoms and venom peptides are sourced from our own venomous animals breeding facilities. Plant extracts and small molecules come from an exclusive partnership with a foreign academic Institution specialized in Plant Biochemistry and Pharmacology. Collaboration with several Research Organizations have enabled LATOXAN to expand its catalog to unique molecules and screening libraries. LATOXAN is also involved in Drug Discovery Research projects on antimicrobials, pain-killing, haematology, cancerology, dermatology. Opportunities exist for investing as equity holders in these promising ventures. Information can be supplied to potential investors under confidentiality agreement. As early as 1982 LATOXAN pioneered in the production of venoms within its facilities based in France and progressively developped a unique know-how for sourcing, farming, breeding and milking over 300 species of snakes, scorpions and batrachians from all over the world. Animals come from breeding or capture missions and are kept several years active and productive. For each production batch LATOXAN is able to provide upon demand certificate of analysis and traceability, certificate of origin, health veterinary certificate and a Venom Production Master File (for pharmaceutical industry). Our venom peptides and plant molecules have a purity ≥95%.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Latoxan has 4 employees across 4 departments.
Departments
Number of employees
Funding Data
Latoxan has never raised funding before.
Latoxan Tech Stack
Discover the technologies and tools that power Latoxan's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Tag managers
Reverse proxies
Programming languages
Font scripts
UI frameworks
Analytics
Ecommerce
Frequently asked questions
4.8
40,000 users



